Canton, MA, United States of America

Michael R Bowman

USPTO Granted Patents = 7 

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Cambridge, MA (US) (1998)
  • Canton, MA (US) (1998 - 2003)
  • Westwood, MA (US) (2006)

Company Filing History:


Years Active: 1998-2006

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Michael R. Bowman: Innovator in Protease Research

Introduction

Michael R. Bowman is a notable inventor based in Canton, MA (US). He has made significant contributions to the field of protease research, holding a total of 7 patents. His work focuses on novel proteases and their applications in treating various medical conditions.

Latest Patents

One of Bowman's latest patents is for an ICE/CED-3 like protease designated FMH-1. This invention discloses polynucleotides encoding novel proteases known as 'FMH-1'. The patent also details host cells transformed with these polynucleotides and methods for producing FMH-1 proteases. Additionally, the invention provides FMH-1 proteases and antibodies that react with them. It includes pharmaceutical compositions comprising FMH-1 proteases or polynucleotides encoding FMH-1 proteases. Furthermore, methods for treating conditions associated with excessive or insufficient apoptosis by administering such pharmaceutical compositions are also disclosed.

Career Highlights

Throughout his career, Michael R. Bowman has worked with prominent organizations, including Genetics Institute, Inc. His innovative research has led to advancements in the understanding and application of proteases in medicine.

Collaborations

Bowman has collaborated with notable individuals in his field, including Kenneth A. Jacobs and John M. McCoy. These partnerships have contributed to the success of his research and patent developments.

Conclusion

Michael R. Bowman is a distinguished inventor whose work in protease research has led to significant advancements in medical treatments. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…